share_log
Breakings ·  Jul 10 19:39
Amylyx Pharmaceuticals Shares up 8.5% Premarket After Completing Acquisition of Experimental Low Blood Sugar Drug
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment